A preliminary pharmacokinetic study of intravenous Photofrin® in patients

Journal of Clinical Laser Medicine and Surgery

Volumn 14, Issue 5, 1996, Pages 311-314

  Bellnier, David A ^a   Dougherty, Thomas J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; COMPOSITION EFFECTS; DRUG PRODUCTS; FLUORESCENCE; ONCOLOGY; PHARMACOKINETICS; PHOTOCHEMICAL REACTIONS; PHOTOSENSITIVITY;

CARCINOMAS; DRUG ACTIVATING LIGHT; INTRAVENOUS PHOTOFRIN; MALIGNANT TUMORS;

PHOTODYNAMIC THERAPY;

PHOTOFRIN;

ARTICLE; BASAL CELL CARCINOMA; BLOOD SAMPLING; BODY WEIGHT; CLINICAL ARTICLE; COMPARTMENT MODEL; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; FLUORESCENCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; MESOTHELIOMA; PHOTODYNAMIC THERAPY; SKIN CARCINOMA;

EID: 0030273608     PISSN: 10445471     EISSN: None     Source Type: Journal    
DOI: 10.1089/clm.1996.14.311     Document Type: Article

References (11)

1. McCaughan, J.S., Jr., Williams, T., Jr., Hawley, P., and Miller, C. (1994). Endobronchial photodynamic therapy for hemoptysis. Prog. Biomed. Optics, SPIE 2133, 2-9.
2. Dougherty, T.J., Cooper, M.T., and Mang, T.S. (1990). Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg. Med. 10, 485-488.
3. Bellnier, D.A., Ho, Y-K., Pandey, R.K., Missert, J.R., and Dougherty, T.J. (1989). Distribution and elimination of Photofrin II in mice. Photochem. Photobiol. 50, 221-228.
4. Lui, H., Hruza, L., Kollias, N., Wimberly, J., Gagel, M., McLean, D., Salvatori, V., and Anderson, R. (1993). Photodynamic therapy of malignant skin tumors with benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem. Photobiol. 57S, 109S.
5. Allan, R.P., Kessel, D., Tharratt, R.S., and Volz, W. (1992). Photodynamic therapy of superficial malignancies with NPe6 in man, in: Photodynamic Therapy and Biomedical Lasers. P. Spinelli, M. Dal Fante, and R. Marchesini (eds.). Amsterdam: Excerpta Medica, pp. 441-445.
6. th Int. Photodynamic Assoc. Biennial Meet., SPIE 2371, 51-58.
7. Brown, S.B., Vernon, D.I., Holroyd, A., Marcus, S., Trust, R., Hawkins, W., Shah A., and Tonelli, A. (1992). Pharmacokinetics of Photofrin in man, in: Photodynamic Therapy and Biomedical Lasers. P. Spinelli, M. Dal Fante, and R. Marchesini (eds.). Amsterdam: Excerpta Medica, pp. 475-479.
8. Ulrich, C., Fox, E., and Shotton, K. (1995). SigmaPlot User's Manual. San Rafael, CA: Jandel Corporation.
9. Beal, S., and Sheiner, L.B. (1982). Estimating population pharmacokinetics. CRC Crit. Rev. Biomed. Eng. 8, 195-222.
10. Boyle, D.G., and Potter, W.R. (1987). Photobleaching of Photofrin II as a means of eliminating skin photosensitivity. Photochem. Photobiol. 46, 997-1001.
11. Bellnier, D.A., and Dougherty, T.J. (1989). The time course of cutaneous porphyrin photosensitization in the murine ear. Photochem. Photobiol. 49, 369-372.